Skip to main content
. 2015 Mar;352(3):480–493. doi: 10.1124/jpet.114.220293

TABLE 1.

Potency and maximal effects of the compounds tested for downstream effectors of the D2R

Data are an average of at least three individual experiments conducted in duplicate. For EC50 values, the 95% confidence interval is shown in parentheses. Maximal effects are shown as a percentage of dopamine’s maximal response, and S.E.M. is shown in parentheses. Potency ratios of β-arrestin recruitment/Gαi/o activation were also included.

Compound β-Arrestin 2 Recruitment
Gαi/o Activation
Gβγ Activation
Potency (EC50) Ratio
EC50 Max Effect
(% Dopamine) EC50 Max Effect
(% Dopamine) EC50 Max Effect
(% Dopamine) β-Arrestin/Gαi/o
nM nM nM
Dopamine 124 (100–153) 100 (± 2) 1.2 (0.7–2.1) 100 (± 3) 171 (72–407) 100 (± 8) 103
Quinpirole 64 (59–70) 96 (± 1) 1.2 (0.9–1.6) 100 (± 2) 145 (89–236) 103 (± 4) 53
Lisuride 0.4 (0.3–0.6) 66 (± 2) 0.07 (0.04–0.14) 106 (± 5) 2.2 (0.4–12.0) 30 (± 6) 9
Bromocriptine 2.9 (1.9–4.4) 101 (± 4) 1.9 (0.9–4.3) 104 (± 3) 0.5 (0.1–2.1) 34 (± 5) 2
Aripiprazole 3.6 (2.5–5.2) 19 (± 1) 1.3 (0.5–3.1) 65 (± 4) ND −19 (± 5) 3
Rotigotine 0.2 (0.1–0.3) 111 (± 4) 0.02 (0.007–0.03) 95 (± 3) 1.5 (0.3–6.9) 54 (± 9) 10
(+)-3-PPP 925 (809–1058) 92 (± 1) 8.6 (4.9–15.1) 108 (± 4) 518 (136–1973) 57 (± 9) 108
RNPA 1.9 (1.5–2.5) 101 (± 2) 13 (3–57) 95 (± 13) 360 (210–619) 110 (± 11) 0.1
Pramipexole 12 (10–15) 94 (± 2) 0.2 (0.1–0.3) 108 (± 3) 20 (9–46) 86 (± 5) 60
Ropinirole 49 (37–63) 92 (± 2) 0.5 (0.3–0.8) 111 (± 4) 100 (34–290) 56 (± 6) 98
Pergolide 7.2 (5.9–8.9) 90 (± 2) 0.04 (0.02–0.07) 101 (± 4) 2.3 (0.6–9.5) 38 (± 7) 180

ND, not determined.